Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Primary Renal Tumour Response in Patients Treated With Nivolumab for Metastatic Renal Cell Carcinoma: Results From the GETUG-AFU 26 NIVOREN TrialEur Urol 2021 Jun 05;[EPub Ahead of Print], J Courcier, C Dalban, B Laguerre, S Ladoire, P Barthélémy, S Oudard, F Joly, G Gravis, C Chevreau, L Geoffrois, É Deluche, F Rolland, D Topart, S Culine, S Négrier, H Mahammedi, F Tantot, A Jamet, B Escudier, R Flippot, L Albigès
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.